SKI Market

A+| A| A-|

Indian Indices

Sensex

73,918.76 394.50
( 0.54%)

Global Indices

Nasdaq

50,812.84 -74.94
(-0.15%)

Dow Jones

7,426.81 22.07
(0.30%)

Hang Seng

65,160.26 1,135.66
(1.77%)

Nikkei 225

10,368.25 0.20
(0.00%)

Forex

USD-INR

95.22 -0.51
(-0.53%)

EUR-INR

109.67 -1.54
(-1.39%)

GBP-INR

126.98 -1.60
(-1.25%)

JPY-INR

0.59 0.00
(-0.77%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

142.97

429145.05

EPS(TTM)

Face Value()

Div & Yield %

12.51

0.89

Back

grp ltd

Tilak Ventures standalone net profit declines 81.72% in the December 2025 quarter

Feb 07,2026

Net profit of Tilak Ventures declined 81.72% to Rs 0.17 crore in the quarter ended December 2025 as against Rs 0.93 crore during the previous quarter ended December 2024. Sales rose 244.07% to Rs 2.03 crore in the quarter ended December 2025 as against Rs 0.59 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.03	0.59	244
OPM %	-103.94	-66.10	-
PBDT	0.62	1.11	-44
PBT	0.62	1.11	-44
NP	0.17	0.93	-82

73,918.76 394.50 ( 0.54%)

50,812.84 -74.94 (-0.15%)

7,426.81 22.07 (0.30%)

65,160.26 1,135.66 (1.77%)

10,368.25 0.20 (0.00%)

95.22 -0.51 (-0.53%)

109.67 -1.54 (-1.39%)

126.98 -1.60 (-1.25%)

0.59 0.00 (-0.77%)